Atlas Trials

A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Participants

Clinical trial NCT05603312 · COMPLETED

Trial details

NCT number
NCT05603312
Sponsor
MeiraGTx, LLC
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Parkinson's Disease
Start date
2022-10-05
Primary completion
2024-09-06
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.